Shopping Cart
- Remove All
- Your shopping cart is currently empty
JSH-0009 dimaleate (Compound 1), a potent CDK9 inhibitor, exhibits an IC50 of 0.928 nM. This compound demonstrably inhibits the growth of subcutaneous tumor (cute myelogenous leukemia MV4-11) in mice.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | JSH-0009 dimaleate (Compound 1), a potent CDK9 inhibitor, exhibits an IC50 of 0.928 nM. This compound demonstrably inhibits the growth of subcutaneous tumor (cute myelogenous leukemia MV4-11) in mice. |
Targets&IC50 | CDK9/cyclinT1:0.928 nM, CDK1/cyclinB:5410 nM, CDK2/cyclinA:6850 nM, CDK3/cyclin E1:>10,000 nM, Cdk5/p25:6950 nM, CDK7/Cyclin H/MNAT1:3700 nM, CDK8/cyclin C:>10,000 nM |
Molecular Weight | 751.25 |
Formula | C33H43ClN6O10S |
Cas No. | 2559759-04-3 |
Storage | store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.